Clinical Trial

Digital CBTI for Comorbid Insomnia in Chronic Migraine

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The overall aims of the study are: Aim 1: Estimate effect sizes: To estimate the effects of dCBT-I on insomnia symptoms compared to a control group (sleep hygiene education) and estimate the relationship between changes in insomnia symptoms and the reduction in migraines. Aim 2: Explore mechanisms of change: To explore the mechanisms underlining the change in migraine symptoms. Aim 3: Assess barriers to conducting a full-scale RCT: To collect data on recruitment pace and dropouts in both groups, which will help refine the methodology and maximise uptake and retention of a full-scale randomised control trial (RCT). The investigators will conduct qualitative interviews with a select number of participants and practitioners to identify motivators/barriers in uptake of a digitalised version of CBT-I.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-02-08; most recent amendment 2025-01-07.
Status change: Recruiting → Active, Not Recruiting 2025-01-07
Trial Details
NCT Number NCT05244889
Lead Sponsor University of Strathclyde
Conditions Insomnia Chronic, Migraine Disorders
Enrollment 88 participants
Start Date 2022-01-31
Primary Completion 2024-07-30 (estimated)
Study Completion 2025-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-01-09